Sabrina Kraus
Oberdürrbacher Str. 6
Wuerzburg, BY 97080, Germany
Wuerzburg, BY 97080, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
MAGIC Composite Score Predicts Outcomes of Second-Line Therapy for Acute GVHD.
Journal: medRxiv : the preprint server for health sciences
Published: July 29, 2026
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.
Journal: British journal of haematology
Published: March 04, 2026
What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantation.
Journal: Annals of hematology
Published: December 23, 2025
Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 12, 2025
Tailored strategies for improved control of CAR-T cells in multiple myeloma.
Journal: Frontiers in immunology
Published: November 05, 2025
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMT.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: October 25, 2025
Comparative proteome analyses of human natural killer cells from patients after allogeneic stem cell transplantation and healthy individuals challenged with Aspergillus fumigatus.
Journal: microLife
Published: September 26, 2025
Venetoclax plus high-dose cytarabine and mitoxantrone as salvage treatment for relapsed or refractory acute myeloid leukaemia (RELAX): a multicentre, single-arm, phase 1/2 trial.
Journal: The Lancet. Haematology
Published: September 01, 2025
Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity.
Journal: Transplantation and cellular therapy
Published: July 31, 2025
Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: July 08, 2025
Human cytomegalovirus control in allogeneic stem cell transplant recipients in the letermovir era - emerging humoral and cellular players.
Journal: Haematologica
Published: May 16, 2025
Last Updated: 09/26/2026